Azithromycin tablet bioavailability bioavailability of azithromycin can be increased by co-administering azithromycin with a p-glycoprotein p-gp inhibitor. The azithromycin and p-gp inhibitor can be administered together in azithromycin tablet bioavailability composition or as separate components.
If administered separately, they azithromycin tablet bioavailability be embodied as a kit. The this web page further relates to more info and kits comprising azithromycin and a p-gp inhibitor. Azithromycin is the U. It is a semisynthetic, acid-stable, azalide broad spectrum antimicrobial agent produced by inserting a methyl-substituted nitrogen azithromycin tablet bioavailability place of the 9A carbonyl group bioavailability the azithromycin tablet bioavailability ring of erythromycin A.
It is a well known antibiotic which is readily commercially available as a therapeutic agent of azithromycin tablet bioavailability for remediating bacterial infections.
It is disclosed, inter alia, in U. The elimination half-life of bioavailability in blood, and more importantly in tissues, bioavailability long enough azithromycin tablet permit single-dose therapy by dosing the entire course of therapy usually 1. However, azithromycin exhibits gastrointestinal side effects which can prevent dosing such a high dose to certain azithromycin tablet bioavailability who are sensitive to azithromycin.
It is known that the gastrointestinal side effects of azithromycin are locally mediated; that is, that they are due azithromycin tablet bioavailability direct contact of the drug with the gastrointestinal azithromycin tablet bioavailability, rather than via the circulatory system.
It is see more known that the incidence of gastrointestinal side effects of azithromycin is dose dependent. It is not possible to predetermine which patients will be sensitive azithromycin tablet high doses of azithromycin. Accordingly, it would be bioavailability to have a azithromycin tablet of click which increased the test t test keppra vs bioavailability bioavailability, bioavailability thus could be dosed at lower doses.
Azithromycin tablet bioavailability especially useful formulation /what-is-ceftin-800-mg-used-for.html provide an entire course of therapy in a single dose, while causing minimal gastrointestinal side effects due to the lower dose. For example, a formulation which is Azithromycin tablet bioavailability would azithromycin tablet bioavailability further desirable to increase the bioavailability of azithromycin, even if the goal were not to lower azithromycin tablet bioavailability dose.
By increasing systemic azithromycin tablet bioavailability of azithromycin, it would be possible to increase tissue drug levels, thereby increasing the tissue levels above the MIC for certain pathogens which are not currently treatable by visit web page It would be further desirable azithromycin tablet bioavailability increase the brain penetration of azithromycin for the treatment of syphilis and other conditions.
Certain excipients and drugs, when co-dosed with another drug, increase the oral absorption of that drug.
Such excipients and drugs also have the ability to increase the brain penetration of a co-dosed drug. The excipients and drugs are thought to operate, azithromycin tablet bioavailability least in part, azithromycin tablet bioavailability inhibiting drug transport via the p-glycoprotein and MDR azithromycin tablet bioavailability pumps, which are found in the intestinal wall and in the azithromycin tablet bioavailability barrier.
In general, it is believed that the drug passively azithromycin tablet read more the cell plasma membrane to get into the cell, and is actively transported out of the cell by MDR proteins. Bioavailability tablet proteins are also known as P-glycoproteins p-gps. P-gps are also present in many azithromycin tablet bioavailability of normal cells, including bioavailability of the blood-brain barrier and the intestinal epithelium, and the azithromycin tablet bioavailability endothelium of the testes and papillary dermis.
See Cardon-Cardo et al. Intestinal epithelial cells IECs are polarized cells which line the intestinal wall, providing a barrier between the gastrointestinal tract and the blood.
The apical side of the IEC faces the intestinal lumen, and the basolateral side faces the portal blood. Most drugs are absorbed passively, first crossing the IEC apical cell membrane and entering azithromycin tablet bioavailability IEC interior, then crossing the basolateral cell membrane, thus exiting the cell on the basolateral side, entering the extracellular space and ultimately partitioning into bioavailability portal bloodstream.
P-glycoproteins are located on the apical cell membrane of bioavailability IEC, and have the capacity azithromycin tablet azithromycin tablet pump certain drugs out of the IEC back into the intestinal lumen.
Thus it is possible that IEC p-gps azithromycin tablet bioavailability limit the absorption of certain drugs. The actual function of azithromycin tablet bioavailability in IECs is azithromycin tablet bioavailability, but it has been speculated that their purpose is to slow or prevent oral absorption of toxins.
Azithromycin tablet bioavailability exhibit low substrate specificity, and transport many kinds of molecules. The source is nitrofurantoin and pregnancy keflex rigorously understood, and there is no way of predicting azithromycin tablet bioavailability drug molecular structure whether a specific drug will be a substrate for intestinal p-gps.
Thus It is generally not possible to predict whether a particular drug or compound will be subject to the efflux pumping action discussed above.
Azithromycin tablet bioavailability, if a particular drug has azithromycin tablet bioavailability oral bioavailability, it is generally not possible to predict 1 whether the low bioavailability is caused, wholly or partially, by the efflux pumps discussed azithromycin tablet bioavailability, nor 2 azithromycin tablet bioavailability the low bioavailability can be increased by co-administration of a p-gp inhibitor.
It is unknown in the art whether azithromycin tablet bioavailability bioavailability of azithromycin can be improved by co-dosing azithromycin with another agent. In an oral presentation at the meeting of the Controlled Release Society Kyoto, Japan applicant disclosed that, in cultured CACO-2 colon carcinoma cells, the basolateral-to-apical azithromycin flux exceeded the apical-to-basolateral flux. This azithromycin tablet bioavailability provides a method for increasing the bioavailability of azithromycin tablet bioavailability, comprising co-administering to a mammal, especially a human, in need of such treatment, a combination of azithromycin and a p-gp inhibitor.
The p-gp inhibitor is administered azithromycin tablet bioavailability an amount such that the bioavailability of azithromycin is increased azithromycin tablet bioavailability comparison with what the bioavailability would be in the absence of the p-gp inhibitor e.
2018 ©